What is Stoke Therapeutics Inc?
engages in the development of treatments for severe genetic diseases by upregulating protein expression.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
engages in the development of treatments for severe genetic diseases by upregulating protein expression. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output (TANGO) approach in developing antisense oligonucleotides (ASOs) to selectively restore protein levels. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 1.75B.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 0 | 0 |
| 3-6months | 0 | 0 |
| 6-9months | 1269,699 shares $2.5M | 0 |
| 9-12months | 847,570 shares $1.5M | 0 |